ASCO 2015 – key takeaways
The annual American Society of Clinical Oncology (ASCO) meeting
traditionally provides a snapshot of the most exciting clinical programs and
science in the field of oncology, a disease category where around 40% of
biopharmaceutical research is focused. After three and a half days of
clinical/scientific presentations and conversations with key opinion leaders
and community oncologists, you get a great sense of where the treatment of
cancer is headed.
